Diagnostic, prognostic and treatment methods

Details for Australian Patent Application No. 2009217433 (hide)

Owner Newcastle Innovation Limited

Inventors Cairns, Murray John

Agent Davies Collison Cave

Pub. Number AU-A-2009217433

Priority 61/157,849 05.03.09 US

Filing date 22 September 2009

Wipo publication date 23 September 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

Event Publications

8 October 2009 Complete Application Filed

  Priority application(s): 61/157,849 05.03.09 US

23 September 2010 Application Open to Public Inspection

  Published as AU-A-2009217433

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009217434-Systems, Methods and Devices Relating to Delivery of Medical Implants

2009217432-Wellsite surface equipment systems